Neuroone Medical Technologies Stock Performance

NMTC Stock  USD 0.83  0.06  6.74%   
On a scale of 0 to 100, Neuroone Medical holds a performance score of 5. The company secures a Beta (Market Risk) of 2.05, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Neuroone Medical will likely underperform. Please check Neuroone Medical's potential upside and the relationship between the skewness and period momentum indicator , to make a quick decision on whether Neuroone Medical's current price movements will revert.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Neuroone Medical Technologies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Neuroone Medical exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Last Split Factor
1:3
Last Split Date
2021-04-01
1
Can NeuroOne Medical Technologies Corporation stock hit analyst price targets - July 2025 Spike Watch Low Risk High Win Rate Stock Picks - newser.com
11/18/2025
2
NeuroOne Announces Initial Successful Cases Completed With OneRF Trigeminal Nerve Ablation System at the University Hospitals in Cleveland
12/09/2025
3
Neuroone Medical is to drop even more in January
12/16/2025
4
Novogradac Conference to Discuss Turning NMTC Permanence into Long-Term Impact
12/17/2025
5
Insider Trading
12/18/2025
6
NeuroOne Medical Technologies Corp Q4 2025 Earnings Call Highlights Record Revenue ...
12/19/2025
7
NeuroOne Medical Technologies Corporation Q4 2025 Earnings Call Transcript
12/23/2025
8
Disposition of 253 shares by Mark Christianson of Neuroone Medical at 0.758 subject to Rule 16b-3
12/31/2025
9
Heartland Renaissance Fund Secures New Markets Tax Credit Allocation to Fuel Economic Growth
01/08/2026
10
Disposition of 71325 shares by Rosa David A of Neuroone Medical at 1.16 subject to Rule 16b-3
01/21/2026
Begin Period Cash Flow1.5 M
Total Cashflows From Investing Activities-81.7 K

Neuroone Medical Relative Risk vs. Return Landscape

If you would invest  72.00  in Neuroone Medical Technologies on November 4, 2025 and sell it today you would earn a total of  11.00  from holding Neuroone Medical Technologies or generate 15.28% return on investment over 90 days. Neuroone Medical Technologies is currently generating 0.3557% in daily expected returns and assumes 5.0394% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than Neuroone, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Neuroone Medical is expected to generate 6.68 times more return on investment than the market. However, the company is 6.68 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Neuroone Medical Target Price Odds to finish over Current Price

The tendency of Neuroone Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.83 90 days 0.83 
about 24.13
Based on a normal probability distribution, the odds of Neuroone Medical to move above the current price in 90 days from now is about 24.13 (This Neuroone Medical Technologies probability density function shows the probability of Neuroone Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.05 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Neuroone Medical will likely underperform. Additionally Neuroone Medical Technologies has an alpha of 0.0323, implying that it can generate a 0.0323 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Neuroone Medical Price Density   
       Price  

Predictive Modules for Neuroone Medical

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neuroone Medical Tec. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.040.835.87
Details
Intrinsic
Valuation
LowRealHigh
0.040.735.77
Details
Naive
Forecast
LowNextHigh
0.020.825.86
Details
1 Analysts
Consensus
LowTargetHigh
2.022.232.47
Details

Neuroone Medical Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Neuroone Medical is not an exception. The market had few large corrections towards the Neuroone Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neuroone Medical Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neuroone Medical within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.03
β
Beta against Dow Jones2.05
σ
Overall volatility
0.1
Ir
Information ratio 0.02

Neuroone Medical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neuroone Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neuroone Medical Tec can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Neuroone Medical Tec had very high historical volatility over the last 90 days
Neuroone Medical Tec has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 12.1 M. Net Loss for the year was (3.61 M) with loss before overhead, payroll, taxes, and interest of (1.23 M).
Neuroone Medical Technologies currently holds about 10.18 M in cash with (2.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Latest headline from MacroaxisInsider: Disposition of 71325 shares by Rosa David A of Neuroone Medical at 1.16 subject to Rule 16b-3

Neuroone Medical Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neuroone Stock often depends not only on the future outlook of the current and potential Neuroone Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuroone Medical's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding40.2 M
Cash And Short Term Investments6.6 M

Neuroone Medical Fundamentals Growth

Neuroone Stock prices reflect investors' perceptions of the future prospects and financial health of Neuroone Medical, and Neuroone Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neuroone Stock performance.

About Neuroone Medical Performance

By analyzing Neuroone Medical's fundamental ratios, stakeholders can gain valuable insights into Neuroone Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Neuroone Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Neuroone Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 236.26  224.44 
Return On Tangible Assets(150.49)(142.97)
Return On Capital Employed 0.84  0.88 
Return On Assets(20.23)(21.25)
Return On Equity 1.00  1.05 

Things to note about Neuroone Medical Tec performance evaluation

Checking the ongoing alerts about Neuroone Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neuroone Medical Tec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Neuroone Medical Tec had very high historical volatility over the last 90 days
Neuroone Medical Tec has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 12.1 M. Net Loss for the year was (3.61 M) with loss before overhead, payroll, taxes, and interest of (1.23 M).
Neuroone Medical Technologies currently holds about 10.18 M in cash with (2.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63.
Latest headline from MacroaxisInsider: Disposition of 71325 shares by Rosa David A of Neuroone Medical at 1.16 subject to Rule 16b-3
Evaluating Neuroone Medical's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Neuroone Medical's stock performance include:
  • Analyzing Neuroone Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neuroone Medical's stock is overvalued or undervalued compared to its peers.
  • Examining Neuroone Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Neuroone Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neuroone Medical's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Neuroone Medical's stock. These opinions can provide insight into Neuroone Medical's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Neuroone Medical's stock performance is not an exact science, and many factors can impact Neuroone Medical's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Neuroone Stock analysis

When running Neuroone Medical's price analysis, check to measure Neuroone Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuroone Medical is operating at the current time. Most of Neuroone Medical's value examination focuses on studying past and present price action to predict the probability of Neuroone Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuroone Medical's price. Additionally, you may evaluate how the addition of Neuroone Medical to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Transaction History
View history of all your transactions and understand their impact on performance
Bonds Directory
Find actively traded corporate debentures issued by US companies